Contact Us

Conventional hematology systems rely on multi-channel architectures, complex reagent chemistries, and expensive consumables. These designs introduce analytical interferences, operational burden,and significant cost—especially limiting point-of-care use and multi-species testing.

VioCyte was formed to take a fundamentally different approach.

Our founders and leadership team share decades of hands-on experience working directly with the most advanced—and most complex—hematology platforms in the industry. That experience led to a clear conclusion: the core diagnostic information clinicians need could be delivered more cleanly, more reliably, and with far fewer moving parts.